Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
about
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathwaysBRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.
P2860
Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Differential requirement for w ...... ouse models of human leukemia.
@en
Differential requirement for w ...... ouse models of human leukemia.
@nl
type
label
Differential requirement for w ...... ouse models of human leukemia.
@en
Differential requirement for w ...... ouse models of human leukemia.
@nl
prefLabel
Differential requirement for w ...... ouse models of human leukemia.
@en
Differential requirement for w ...... ouse models of human leukemia.
@nl
P2093
P2860
P1476
Differential requirement for w ...... ouse models of human leukemia.
@en
P2093
Hans-Willem Snoeck
Kenjiro Kamezaki
Larry L Luchsinger
P2860
P304
192-203.e1
P356
10.1016/J.EXPHEM.2013.11.008
P577
2013-11-20T00:00:00Z